C-Jun N-terminal kinase inhibitors: Structural insight into kinase-inhibitor complexes
The activation of c-Jun N-terminal kinases (JNKs) plays an important role in physiological processes including neuronal function, immune activity, and development, and thus, JNKs have been a therapeutic target for various diseases such as neurodegenerative diseases, inflammation, and cancer. Efforts...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Computational and Structural Biotechnology Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2001037020303020 |
id |
doaj-43e7cb1b698640da9d3a4027d3c6fbfa |
---|---|
record_format |
Article |
spelling |
doaj-43e7cb1b698640da9d3a4027d3c6fbfa2021-01-02T05:08:42ZengElsevierComputational and Structural Biotechnology Journal2001-03702020-01-011814401457C-Jun N-terminal kinase inhibitors: Structural insight into kinase-inhibitor complexesMen Thi Hoai Duong0Joon-Hwa Lee1Hee-Chul Ahn2Department of Pharmacy, Dongguk University-Seoul, Goyang, Gyeonggi 10326, South KoreaDepartment of Chemistry and RINS, Gyeongsang National University, Jinju, Gyeongnam 52828, South Korea; Corresponding authors.Department of Pharmacy, Dongguk University-Seoul, Goyang, Gyeonggi 10326, South Korea; Corresponding authors.The activation of c-Jun N-terminal kinases (JNKs) plays an important role in physiological processes including neuronal function, immune activity, and development, and thus, JNKs have been a therapeutic target for various diseases such as neurodegenerative diseases, inflammation, and cancer. Efforts to develop JNK-specific inhibitors have been ongoing for several decades. In this process, the structures of JNK in complex with various inhibitors have contributed greatly to the design of novel compounds and to the elucidation of structure-activity relationships. Almost 100 JNK structures with various compounds have been determined. Here we summarize the information gained from these structures and classify the inhibitors into several groups based on the binding mode. These groups include inhibitors in the open conformation and closed conformation of the gatekeeper residue, non-ATP site binders, peptides, covalent inhibitors, and type II kinase inhibitors. Through this work, deep insight into the interaction of inhibitors with JNKs can be gained and this will be helpful for developing novel, potent, and selective inhibitors.http://www.sciencedirect.com/science/article/pii/S2001037020303020c-Jun N-terminal kinase (JNK)InhibitorComplex structureStructure-activity relationshipGatekeeper |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Men Thi Hoai Duong Joon-Hwa Lee Hee-Chul Ahn |
spellingShingle |
Men Thi Hoai Duong Joon-Hwa Lee Hee-Chul Ahn C-Jun N-terminal kinase inhibitors: Structural insight into kinase-inhibitor complexes Computational and Structural Biotechnology Journal c-Jun N-terminal kinase (JNK) Inhibitor Complex structure Structure-activity relationship Gatekeeper |
author_facet |
Men Thi Hoai Duong Joon-Hwa Lee Hee-Chul Ahn |
author_sort |
Men Thi Hoai Duong |
title |
C-Jun N-terminal kinase inhibitors: Structural insight into kinase-inhibitor complexes |
title_short |
C-Jun N-terminal kinase inhibitors: Structural insight into kinase-inhibitor complexes |
title_full |
C-Jun N-terminal kinase inhibitors: Structural insight into kinase-inhibitor complexes |
title_fullStr |
C-Jun N-terminal kinase inhibitors: Structural insight into kinase-inhibitor complexes |
title_full_unstemmed |
C-Jun N-terminal kinase inhibitors: Structural insight into kinase-inhibitor complexes |
title_sort |
c-jun n-terminal kinase inhibitors: structural insight into kinase-inhibitor complexes |
publisher |
Elsevier |
series |
Computational and Structural Biotechnology Journal |
issn |
2001-0370 |
publishDate |
2020-01-01 |
description |
The activation of c-Jun N-terminal kinases (JNKs) plays an important role in physiological processes including neuronal function, immune activity, and development, and thus, JNKs have been a therapeutic target for various diseases such as neurodegenerative diseases, inflammation, and cancer. Efforts to develop JNK-specific inhibitors have been ongoing for several decades. In this process, the structures of JNK in complex with various inhibitors have contributed greatly to the design of novel compounds and to the elucidation of structure-activity relationships. Almost 100 JNK structures with various compounds have been determined. Here we summarize the information gained from these structures and classify the inhibitors into several groups based on the binding mode. These groups include inhibitors in the open conformation and closed conformation of the gatekeeper residue, non-ATP site binders, peptides, covalent inhibitors, and type II kinase inhibitors. Through this work, deep insight into the interaction of inhibitors with JNKs can be gained and this will be helpful for developing novel, potent, and selective inhibitors. |
topic |
c-Jun N-terminal kinase (JNK) Inhibitor Complex structure Structure-activity relationship Gatekeeper |
url |
http://www.sciencedirect.com/science/article/pii/S2001037020303020 |
work_keys_str_mv |
AT menthihoaiduong cjunnterminalkinaseinhibitorsstructuralinsightintokinaseinhibitorcomplexes AT joonhwalee cjunnterminalkinaseinhibitorsstructuralinsightintokinaseinhibitorcomplexes AT heechulahn cjunnterminalkinaseinhibitorsstructuralinsightintokinaseinhibitorcomplexes |
_version_ |
1724359684682416128 |